Thursday, March 02, 2017 7:27:29 PM
Check out this chart comparison between LCTC and BLOZF:
(http://bigcharts.marketwatch.com/interchart/interchart.asp?symb=lctc&insttype=&time=8&freq=1)
Under chart controls add compare, enter stock - BLOZF and go to a 2 year time frame.
You will see that up until Jan 2016 we were basically lock step with each other but something happened in early 2016 where BLOZF began to separate itself and move higher. This chart tells me that LCTC is anywhere from 2-4 times undervalued compared to BLOZF. I don't think anyone can argue BLOZF is a much better company when it comes to promotion, blogging, social media, news, Press releases, ihub awareness, etc, but this chart comparison tells me at some point LCTC has some catching up to do.
I fully expect to get close to record revenues from LCTC this quarter. If we don't see revenues over $2 million, that would be disappointing. I don't mind if we see increased spending on research and development but with all the research I have done, their sector is seeing tremendous growth and I expect LCTC to have participated in that growth, domestic and international. I would also like to see at least a half page update on the marijuana breathalyzer in the annual report. Ideally, we get an update outside of the annual report. It's been over a year since we have seen or heard from them on that front and we are overdue.
Here's to getting some good/great news out of this company in the near future. Thanks and all the best.
Recent LCTC News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:14:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:46:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 02:57:07 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/23/2023 02:57:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 09:11:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:21:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM